Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2
Anna Vihola(University of Helsinki), Bjarne Udd(Folkhälsans Forskningscentrum), Rosanna Cardani(IRCCS Policlinico San Donato), Jeanette Holmlund-Hampf(University of Helsinki), Shodimu-Emmanuel Olufemi(The University of Texas MD Anderson Cancer Center), Linda L. Bachinski(Baylor College of Medicine), Mario Sirito(Inserm), G. Meola(IRCCS Policlinico San Donato), Tiina Suominen(Tampere University), Hannu Kalimo(University of Turku), Shohrae Hajibashi(The University of Texas MD Anderson Cancer Center), Hannu Haapasalo(Tampere University Hospital), Ralf Krahe(University of Helsinki), Keith Baggerly(The University of Texas MD Anderson Cancer Center), Anders Paetau(Helsinki University Hospital), Olayinka Raheem(Tampere University Hospital), Lars Edström(Karolinska Institutet)
Cited by 73
Related Papers
Severe iron deficiency anemia in transgenic mice expressing liver hepcidin
|Proceedings of the National Academy of Sciences|2002|882
Mutations in the Gene for Cardiac Myosin-Binding Protein C and Late-Onset Familial Hypertrophic Cardiomyopathy
|New England Journal of Medicine|1998|759
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
|Cancer Cell|2018|705
The myotonic dystrophies: molecular, clinical, and therapeutic challenges
|The Lancet Neurology|2012|487
Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein Titin
|The American Journal of Human Genetics|2002|484